Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/28099
DC FieldValueLanguage
dc.contributor.authorFilip Djokoski,en_US
dc.contributor.authorHiljadnikova bajro, Marijaen_US
dc.date.accessioned2023-10-04T12:38:09Z-
dc.date.available2023-10-04T12:38:09Z-
dc.date.issued2023-
dc.identifier.citationDjokoski F. Hiljadnikova-Bajro M., The Impact of the Human Microbiome on Cancer Immunotherapy, Macedonian pharmaceutical bulletin, 2023: 69 (Suppl 1) 271 - 272en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12188/28099-
dc.language.isoenen_US
dc.publisherMacedonian Pharmaceutical Associationen_US
dc.relation.ispartofMacedonian pharmaceutical bulletin, 69 (Suppl 1) 271 - 272 (2023)en_US
dc.subjectmicrobiota, microbiome, immunotherapy, canceren_US
dc.titleThe Impact of the Human Microbiome on Cancer Immunotherapyen_US
dc.typeJournal Articleen_US
dc.relation.conference14th Central European Symposium on Pharmaceutical Technology, September 28-30, 2023 Ohrid, N. Macedoniaen_US
dc.identifier.doiDOI:10.33320/maced.pharm.bull.2023.69.03.132-
dc.identifier.eissn1857 - 8969-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Pharmacy-
Appears in Collections:Faculty of Pharmacy: Journal Articles
Show simple item record

Page view(s)

40
checked on May 9, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.